中核科技(000777.SZ):聯合投資體確定以現金認購西儀公司新增註冊資本
格隆匯4月13日丨中核科技(000777.SZ)公佈,公司於2019年12月30日以通訊表決方式召開第七屆董事會第八次會議審議《關於參與競拍西安中核核儀器有限公司增資擴股暨關聯交易的議案》,同意公司參加投資聯合體參與競拍,出資金額2000萬元。
經北京產權交易所公開掛牌徵集投資人及投資資格確認,近期公司參與的聯合投資體與西安中核核儀器有限公司(“西儀公司”)簽署了《增資協議》,聯合投資體確定以現金認購西儀公司新增註冊資本。公司現金出資2000萬元,認購新增註冊資本135.736747萬元,佔西儀公司增資後總股份的1.12%,其餘的1864.263253萬元計入資本公積。目前,公司已完成出資。
西儀公司增資擴股後,其註冊資本從人民幣8710.77萬元增加至人民幣12104.188675萬元,原股東持有71.96%股份,新股東持有28.04%股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.